Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
13.71
-0.29 (-2.07%)
Jun 27, 2025, 4:00 PM - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $893.55 million as of June 27, 2025. Its market cap has increased by 37.60% in one year.
Market Cap
893.55M
Enterprise Value
550.53M
1-Year Change
37.60%
Ranking
Category
Stock Price
$13.71
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $893.55M, an increase of 42.99%. That is a compound annual growth rate of 16.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 894.86M | 46.06% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.51B |
| Johnson & Johnson | 366.37B |
| AbbVie | 330.49B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.38B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.42B |
| AstraZeneca | 216.45B |